Searchable abstracts of presentations at key conferences in endocrinology

ea0016p94 | Bone and calcium | ECE2008

Scintigraphic, biochemical and clinical response to zoledronic acid treatment in patients with Paget's disease of bone

Avramidis Avraam , Polyzos Stergios , Moralidis Efstratios , Arsos Georgios , Efstathiadou Zoe , Karakatsanis Konstantinos , Grollios Georgios , Kita Marina

Introduction: Bisphosponates have long been used with success in the treatment of Paget’s disease of bone (PDB). The aim of this study was to evaluate the early (up to three months) and late (at twelve months) scintigraphic, biochemical and clinical response to a single intravenous infusion of zoledronic acid (ZOL) in patients with PDB serially assessed for one year.Materials and methods: Nine patients with 30 bone lesions due to PDB were prospectiv...